Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
Clinical trial NCT00210496 · COMPLETED
Trial details
- NCT number
- NCT00210496
- Sponsor
- Janssen-Ortho LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.